BioNTech SE (BNTX)

NASDAQ: BNTX · USD

$88.0

+0.97 (+1.1%)· Recorded snapshot

Market cap	22.1B
Revenue (ttm)	3B
Net income (ttm)	-1.9B
EPS (ttm)	-$7.77
Shares out	251.2M
Volume	796,169
Beta	1.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): -1.9B
EPS (ttm): -$7.77
Market cap: 22.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-9.3

P25 -113.8P50 -46.5P75 -0.9

ROIC-36.7

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All BNTX indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

EUR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001776985
Company name	BioNTech SE
Country	Germany
Country code	US
CUSIP number	09075V102
Earnings date	2026-11-03
Earnings time	bmo
Employees	7,807
Employees change	1,035
Employees growth	15.28%
Enterprise value	$7.1B
Exchange	NASDAQ
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Biotechnology
IPO date	2019-10-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US09075V1026
Last 10-K release date	2026-03-10
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$22.1B
Market cap category	Large-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$88.03
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	BNTX
Website	https://www.biontech.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-8.83%
EV/FCF	13.43x
EV/Sales	2.32x
FCF / EV yield	7.45%
FCF yield	2.37%
Forward EV/Sales	3.42x
Forward P/S	10.75x
P/(FCF - SBC) ratio	49.61x
P/(OCF - SBC) ratio	32.47x
P/B ratio	1.08x
P/FCF ratio	42.17x
P/OCF ratio	29.11x
P/S ratio	7.28x
Price / tangible book value	1.21x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-68.57%
EBITDA margin	-52.11%
FCF margin	17.71%
Gross margin	76.62%
Operating margin	-68.57%
Pretax margin	-61.49%
Profit margin	-63.64%
Profit per employee	$-246,785
Revenue per employee	$387,797
ROA	-5.41%
ROA (5Y)	27.18%
ROCE	-9.88%
ROE	-9.3%
ROE (5Y)	41.92%
ROIC	-36.69%
ROIC (5Y)	51.46%
SBC / revenue	2.66%
Tax / revenue	2.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth 3Y	-62.63%
Gross profit growth	-11.56%
Gross profit growth (Q)	-95.34%
Gross profit growth 3Y	-36.66%
Gross profit growth 5Y	-21.01%
Net income growth years	0
OCF growth (Q)	-92.83%
OCF growth 3Y	-58.22%
Revenue growth	-7.94%
Revenue growth (Q)	-59.51%
Revenue growth (QoQ)	-10.58%
Revenue growth 3Y	-33.92%
Revenue growth 5Y	-19.36%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-234.5M
Depreciation and amortization	$485.9M
EBIT	$-2.1B
EBITDA	$-1.6B
EPS	$-7.77
FCF per share	$2.08
Financing cash flow	$-123.3M
Free cash flow	$522.7M
Free cash flow minus SBC	$444.2M
Gross profit	$2.3B
Income taxes	$65M
Investing cash flow	$-1.3B
Net borrowing	$26M
Net cash flow	$-603.8M
Net income	$-1.9B
Operating cash flow minus SBC	$678.7M
Operating income	$-2.1B
Revenue	$3B
Stock-based compensation	$80.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.71
Book value per share	$80.76
Debt / equity	0.02
Debt / FCF	0.69
Goodwill	$415.8M
Interest coverage	-127.06
Long-term assets	$6.2B
Long-term liabilities	$782.1M
Net cash (debt)	$15B
Net cash / market cap	68.16%
Net cash growth	-1.62%
Net debt / equity	-0.74
Net debt / FCF	-28.74
Piotroski F-Score	2
Property, plant and equipment	$1.4B
Shareholders' equity	$20.3B
Tangible book value	$18.2B
Tangible book value per share	$72.60
Total assets	$23.2B
Total cash	$15.4B
Total debt	$361.1M
Total liabilities	$3B
WACC	11.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.13
Current assets	$17B
Current liabilities	$2.2B
Current ratio	7.85
Inventory turnover	3.74
Net working capital	$-66.9M
Quick ratio	7.03
Working capital	$15.2B
Working capital turnover	0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$2.13
Shareholder yield	-3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$94.86
1D price change	1.11%
1M price change	-11.32%
1M total return	-11.32%
1W price change	-4.17%
1W total return	-4.17%
1Y price change	-17.61%
1Y return CAGR	-17.63%
1Y total return	-17.61%
20-day SMA	$91.68
200-day SMA	$97.29
3M price change	-4.08%
3M total return	-4.08%
3Y price change	-4.2%
3Y return CAGR	-1.42%
3Y total return	-4.2%
50-day SMA	$98.16
50-day SMA vs 200-day SMA	50over200
52-week high	$124.00
52-week high date	2026-01-22
52-week low	$79.52
52-week low date	2026-03-10
5Y price change	-68.66%
5Y return CAGR	-20.56%
5Y total return	-68.36%
6M price change	-14.39%
6M total return	-14.39%
All-time high	$464.00
All-time high date	2021-08-10
All-time low	$12.53
All-time low date	2019-10-14
Average true range (ATR)	$3.02
Average volume	1.1M
Beta (1Y)	1.36
Beta (2Y)	0.99
Beta (5Y)	1.25
Change from 52-week high	-29.01%
Change from 52-week low	10.7%
Change from all-time high	-81.17%
Change from all-time low	597.56%
Change from open	2.13%
Day's gap	-1%
Dollar volume	$70.1M
High price	$88.17
Low price	$85.82
Monthly RSI	43.85
Open price	$86.19
Position in 52-week range	94.04%
Premarket change	-0.17%
Premarket close	$87.06
Premarket price	$86.91
Premarket volume	2.1K
Previous close	$87.06
Price vs 150-day SMA	-7.9%
Price vs 20-day SMA	-4.7%
Price vs 200-day SMA	-10.2%
Price vs 50-day SMA	-10.99%
Relative volume	0.69
Return from IPO open	431.7%
Return from IPO price	484.87%
RSI	37.67
Sharpe ratio	-0.27
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	-0.24
Sortino ratio	-0.27
Sortino ratio (3Y)	0.29
Sortino ratio (5Y)	-0.24
Volume	796.2K
Weekly RSI	42.29
YTD price change	-8.22%
YTD total return	-8.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109.3M
Float percentage	43.5%
Shares change (QoQ)	0.02%
Shares change (YoY)	3%
Shares held by insiders	16.01%
Shares held by institutions	20.3%
Shares outstanding	251.2M
Short % of shares	3.74%
Short ratio	2.9 days

Deeper analysis on BNTX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BNTX report

Is a complete BNTX research report available?

No complete published report is available for BioNTech SE (BNTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BioNTech SE (BNTX)

Price

Financial snapshot

Fair-value bridge

Latest news · BNTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BNTX

Frequently asked questions